Skip to main content
LNA Santé logo

LNA Santé — Investor Relations & Filings

Ticker · LNA ISIN · FR0004170017 LEI · 969500FULTKJYIRIAT87 PA Human health and social work activities
Filings indexed 557 across all filing types
Latest filing 2020-07-09 Share Issue/Capital Cha…
Country FR France
Listing PA LNA

About LNA Santé

https://www.lna-sante.com/

LNA Santé is a healthcare operator focused on providing care for vulnerable individuals. The company manages and operates a diverse network of facilities, including medicalized nursing homes that offer long-term care and specialized support for neurodegenerative diseases like Alzheimer's and Parkinson's. Its portfolio also includes Medical Care and Rehabilitation (SMR) establishments for post-acute and follow-up care, surgical clinics, and mental health clinics. In addition to its residential and outpatient facilities, LNA Santé provides hospital-at-home (HAD) services, delivering complex medical care directly to patients' residences. The organization's integrated approach serves individuals facing temporary or permanent loss of autonomy, disabilities, or the need for specialized medical treatment and rehabilitation.

Recent filings

Filing Released Lang Actions
LNA Santé : répartition de capital et des droits de vote attachés aux actions au 30/06/2020
Share Issue/Capital Change Classification · 95% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides a breakdown of the company's capital and voting rights ("Répartition de capital et des droits de vote") as of a specific date (30/06/2020). This type of mandatory disclosure, detailing the total number of shares and voting rights, is a standard regulatory filing in France (AMF regulation). It does not fit the specific definitions for Annual Reports (10-K), Earnings Releases (ER), or Dividend Notices (DIV). Since it is a specific regulatory disclosure concerning capital structure and voting rights that doesn't map perfectly to the other specialized codes (like DIRS, MRQ, or SHA which focus on transactions or ownership changes), the most appropriate general category for specific regulatory disclosures that don't fit elsewhere is Regulatory Filings (RNS). However, given the content is strictly about the total number of shares and voting rights, it is a fundamental disclosure related to capital structure, which often falls under general regulatory reporting requirements. Given the options, RNS serves as the best fit for a specific, non-standard regulatory declaration not covered by the other codes.
2020-07-09 French
LNA SANTE: discussion pour l’acquisition du groupe Clinique Développement
M&A Activity Classification · 99% confidence The document is a press release dated June 18, 2020, announcing that LNA Santé is in exclusive discussions to acquire Clinique Développement. This concerns a potential merger or takeover bid. Based on the definitions, this activity falls under 'M&A Activity'. The corresponding code is TAR (Merger/Takeover Activity). The document is short and contains the core announcement, not a detailed report, making TAR the most appropriate classification over a general regulatory filing (RNS).
2020-06-18 French
LNA Santé : descriptif du programme de rachats d'actions
AGM Information Classification · 99% confidence The document is titled "DESCRIPTIF DU PROGRAMME DE RACHAT D'ACTIONS" (Description of the Share Repurchase Program) and details the legal framework, objectives, maximum number of shares, and price limits for the company buying back its own stock. This directly corresponds to the definition of a document reporting the company's intention or execution of buying back its own shares. The relevant filing category is 'Transaction in Own Shares' (Code: POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses purely on the mechanics and authorization of share repurchases.
2020-06-18 French
LNA SANTE - AGM du 17.06.2020 : Modalités de mise à disposition des documents préparatoires
AGM Information Classification · 98% confidence The document explicitly discusses the 'ASSEMBLEE GENERALE MIXTE DU 17 JUIN 2020' (Mixed General Meeting of June 17, 2020) and details the modalities for making preparatory documents available, voting procedures (by correspondence or proxy), and where the recording will be available. This content directly relates to the procedures and materials surrounding the Annual General Meeting (AGM). Although it mentions the 'avis de réunion' and 'avis de convocation' (which could suggest RPA or PSI), the primary focus is on the logistics and documentation related to the AGM itself. Therefore, AGM Information (AGM-R) is the most appropriate classification.
2020-05-12 French
LNA SANTE: Chiffre d'Affaires 1er trimestre 2020
Earnings Release Classification · 98% confidence The document is a press release dated May 5, 2020, detailing the company's financial performance for the 'Premier trimestre 2020' (First Quarter 2020). It presents key financial figures (Chiffre d'affaires, Croissance organique) and provides management commentary on business trends, heavily influenced by the COVID-19 crisis. This structure—a brief announcement focusing on key financial highlights for a specific reporting period (Q1)—is characteristic of an Earnings Release (ER). Although it contains some operational details, it is not the comprehensive 'Interim Report' (IR) itself, nor is it a full transcript (CT) or a formal Annual Report (10-K). It also mentions the upcoming Annual General Meeting (AGM) details, but the primary focus is the quarterly financial results announcement. Q1 2020
2020-05-05 French
LNA Santé : répartition de capital et des droits de vote attachés aux actions au 29/02/2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides the "Répartition de capital et des droits de vote attachés aux actions au 29/02/2020" (Capital and voting rights breakdown as of 29/02/2020). This type of mandatory disclosure, detailing the total number of shares, gross voting rights, and exercisable voting rights, is a standard regulatory filing in France (AMF regulation). Since it is a specific regulatory disclosure about capital structure and voting rights that doesn't fit perfectly into the other specific categories (like 10-K, ER, or DIV), it falls best under the general 'Regulatory Filings' category (RNS) or potentially a specific capital/share related category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for specific, non-periodic regulatory disclosures that aren't about insider trading (DIRS) or major shareholdings (MRQ), although it relates to capital structure. However, looking closely at the definitions, it is a specific regulatory announcement regarding the capital structure and voting rights, which is a form of regulatory reporting. Since there isn't a specific code for 'Voting Rights Disclosure', RNS is the best fit as a general regulatory filing.
2020-03-03 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.